Fundamentals Overview
Insulet Corporation is near the low of its 52-week range with premium valuation, trading relatively flat today.
Valuation premium
Profitability
Risk (Beta)
1.47 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Analyst grade: B-
Pressures (Sell):
Sentiment weakening (2 downgrades) · 3M vs S&P 500: -28% · 3M vs Healthcare sector: -21.2% · Beta 1.47 (elevated)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 17, Equal Weight: 1, Neutral: 2, Outperform: 7, Overweight: 2, Underweight: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-28.89; current price is $202.50. That’s a -114.3% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 57.91 |
| PEG (TTM) | N/A |
| P/B (TTM) | 9.4 |
| P/S (TTM) | 5.26 |
| P/FCF (TTM) | 37.74 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.78 |
| Quick Ratio (TTM) | 2.11 |
| Cash Ratio (TTM) | 1.05 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 9.12% |
| Gross margin (TTM) | 71.63% |
| Operating margin (TTM) | 17.5% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for PODD.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Goldman Sachs | maintain | Buy | Buy | 2026-04-09 |
| Citigroup | downgrade | Buy | Neutral | 2026-04-07 |
| Citigroup | maintain | Buy | Buy | 2026-03-11 |
| Oppenheimer | maintain | Outperform | Outperform | 2026-02-19 |
| JP Morgan | maintain | Overweight | Overweight | 2026-02-19 |
| Truist Securities | maintain | Buy | Buy | 2026-02-19 |
| Citigroup | maintain | Buy | Buy | 2026-02-19 |
| Goldman Sachs | maintain | Buy | Buy | 2026-02-19 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-02-19 |
| Leerink Partners | maintain | Outperform | Outperform | 2026-02-19 |
| Canaccord Genuity | maintain | Buy | Buy | 2026-02-19 |
| Bernstein | maintain | Outperform | Outperform | 2026-02-19 |
| BTIG | maintain | Buy | Buy | 2026-02-18 |
| Stifel | maintain | Buy | Buy | 2026-02-04 |
| Barclays | downgrade | Equal Weight | Underweight | 2026-01-12 |
| Bernstein | maintain | Outperform | Outperform | 2026-01-09 |
| Truist Securities | maintain | Buy | Buy | 2025-12-18 |
| Canaccord Genuity | maintain | Buy | Buy | 2025-12-17 |
| Canaccord Genuity | maintain | Buy | Buy | 2025-11-24 |
| BTIG | maintain | Buy | Buy | 2025-11-21 |
| Truist Securities | maintain | Buy | Buy | 2025-11-21 |
| RBC Capital | maintain | Outperform | Outperform | 2025-11-21 |
| UBS | upgrade | Neutral | Buy | 2025-11-19 |
| BTIG | maintain | Buy | Buy | 2025-11-13 |
| UBS | maintain | Neutral | Neutral | 2025-11-07 |
| Barclays | maintain | Equal Weight | Equal Weight | 2025-11-07 |
| Truist Securities | maintain | Buy | Buy | 2025-11-07 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-11-07 |
| RBC Capital | maintain | Outperform | Outperform | 2025-11-07 |
| Canaccord Genuity | maintain | Buy | Buy | 2025-11-07 |